The core activity of Neurix SA is the development and provision of human stem cell-based services for drug discovery and development, particularly in the field of neurology. This includes the creation of 3D neural tissue models, the development of in vitro models for neurodegenerative diseases, and the conduct of high-throughput screenings for the evaluation of drug candidates.
Human cellular model systems for compound screening and neuroscience research, based on human iPSC-derived in vitro cell models that replicate brain physiology and pathology.
Glioblastoma Invasion Model
Glioblastoma-organoid assembloids for drug testing on tumour growth, motility and metastasis, with assessment of effects on healthy brain organoid tissue.
Blood-Brain Barrier Model
In vitro blood-brain barrier model for studying permeability, drug transport and neurovascular interactions, including compound penetration and barrier integrity readouts.
Alzheimer’s Disease Model
3D human neural and organoid models for Alzheimer’s disease, supporting drug and compound screening, cell and gene therapy testing, and mechanism-of-action studies.
Parkinson’s Disease Model
Human organoid model for Parkinson’s disease, supporting drug and compound screening, cell and gene therapy testing, and mechanism-of-action studies.
Knowledge
No knowledge articles yet
Once Neurix SA has claimed this profile, we'll publish editorial articles and case studies here together.